NEW PRODUCTS - APRIL, 1953

• Document Type: CREST
• Collection: General CIA Records
• Document Number (FOIA) /ESDN (CREST): CIA-RDP83-00423R000700410009-0
• Release Decision: RIPPUB
• Original Classification: K
• Document Page Count: 7
• Document Creation Date: November 9, 2016
• Document Release Date: February 8, 1999
• Sequence Number: 9
• Publication Date: May 4, 1953
• Content Type: MEMO

Approved For Release 1999/09/10 : CIA: RDP83-00423R000700410009-0
I3fPl-O. FICE M i MORA.N)I.IM
25X1X6
TO:
FROM
>I BJECT: New Products - April., 19,53
8 6,
DATE: May It, 1953
Domestic
25X1X
B -liliin iaitn Sulfose Tablets
Wyeth has now introduced Bicillin with Sulfa in
a tablet form. It is supplied in bottles of 36
tablets., For a full description? see BiCillin
Sulfas, New Products, Nov mber, 1952,
Bacitracin Ointment
--~ - - of infection following minor
Ad-:nini stration
Bacitracin Parenteral
Descrtip? on: Each vial contains:
Bacitracin
:i ndi_cations: Against a broad range of gram-positive
sl.dmi..nistration a
orr:i Supplied:
Source: 25X1 X6
In the prevenW'J
cuts and abrasions,
Apply 1 or 2, t=imes daily.
organisms acid penicillin-resistant
strains.
For hospitalized patients only., amount
as determined by physi ciaar.In vials as a dry powder.
Diatracin
Description: Each grv n contains;:
Bacitraoin
Sulfadiazine
Form Supplied: Topical Ointment tubes of z oz.
Source: 25X1 X6
Ui_crysticin
Tjscripti"~on.
Approved For Release
50,000 units
500 units
0?05 Gm.
The for aula for this product has been
changed from:
Procaine Penicillin G 300,000 units
Buffered. Crystalline Penicillin 100,000 units
G Potassium
Dihydroatreptoiigcin Sulfate 005 Gm
PO& 000 units
Procaine Penicillin G 300s
Potassium Penicillin G 100,000 units
Streptomycin Sulfate 0.25 Gm.
' @ Rh 9 ,i-QQ4Y3B@00700410009-0 0,25 Gm.
 Approved For Release 1999/09/10 : CIA,RDP83-00423R000700410009-0
Dicrysticin Fortis
This dosage form contains the same amounts
of penicillin plus 0.5 Cam. each of Streptomycin
and Dihydrostreptomycin Sulfate.
Distrycillin -. aqueous suspension
Procaine- Penicillin Q 400.,000 units
Streptomycin Sulfate 0.25 Cm.
25X1 X6 ostre tom cin Sulfate 0.25 Gm,
Dihydro Dispolator.
Description:
Adinini stration
Form Supplied:
Source:
Each dispolator contains 50 mg, micro-
pulverized dihydrostreptomycin sulfate in
disposable plastic inhalor.
Recommended for local treatment of infec-
tions of the respiratory tract.
2 Dispolators three times a day
2 vials, each containing 3 dispolators
Duo-Stre 25X1 X6
Des ption: A white powder containing the equivalent of
1 Cam. free base of streptomycin sulfate and
dihydrostreptomycin sulfate in equal. parts.
Indications: it is indicated in the treatment of pulmonary,
meningeal, miliary, genitourinary, skeletal,
serosal tuberculosis and tuberculous adenitis.
It can be used where protracted treatment is
necessary as toxicity is greatly reduced.
Administration: As in the case of Streptomycin or Dihydro-
streptomy'cin, it is best used in conjunction
with another anti-TB drug such as PAS or
Isoniazid.
Form Supplied: Vials containing the equivalent of 1 gm. free
. _ ____-- _.-s .aa la...$msnaFrrJnF.hmvriri
25X1X6
fate
Neomycin Ointment, Neomycin Ophthalmic Ointment
Description: Both ointments contain:
Neomycin Sulfate
Indications: Impetigo, wound infections, sycosis
barbae, conjunctivitis, burns, styes,
boils, etc.
Administration: Applied 3 or I times daily.
Form Supplied: Ointment -- Tubes ' oz., 1 oz., 4 oz.
Ophthalmic Ointment -- 1/8 oz. tubes
5 mg. per Clan?
Source: Eli Lilly & Co., Indianapolis, Indiana
Neo cin and Kaolin
Description: This product is an aqueous preparation of
neomycin sulfate, with kaolin and pectin
suspended with methycellulose.
Approved For Release 1999/09/10 : CIA-RDP83-00423R000700410009-0
 Approved For Release 1999/09/10 : CIA-RDP83-00423R000700410009-0
Neozn, ciy n and Kaolin coat' d. r
Indications: Designed for the symptom.'tic treatment of
25X1X6
diarrhea and. as a. specific therapy in
bacterial diarrhea caused. by neonwcin-susceptible
oreani. sma .
Panbiotic
ascription: Each dose contains:
Procaine Penicillin G, Cryst. 300,000 units
Potassium Penicillin G 300,000 units
DBEI) Peni ci llin 600,000 units
Buffering agent in dry form
Form Supplied: 1-dose vials containing 1.2 million units
5 -dose vials containing 6.0 million units
Source: 25X1X6
Pansulfa with Penicillin -- New Package Size
Description: This product combines penicillin with
triple-self onomides .
Indications: For treatment of infections which respond
to oral administration of penicillin and
triple-sulfonamide combinations.
Administration: As determined b?r the physician
Form Suppl. Now available in bottles of. 100 tablets
X1 X6 no twi, Aa in bottles of 21t and 30
Pastillas Antibioticas or Pastillas PSS
Description: Each lozenge contains: l 000 U.I.
Calcium Penicillin
Streptomycin 2,000 U. (2 mg.)
Sulfadiazine 100 mg.
Indications: Used in treating infections of the gums, mouth and
throat caused by Gram-negative or Gram-positive
organisms sensitive to these antibiotics, Used
also in operations on the oral cavity.
Administration: Take one lozenge and allow it to dissolve slowly
in the mouth to permit contact with the in-
fected area for as long as possible.
25X1X6
n tion: Each vial contains:
INx 25X1 X6
Dihydrostreptomycin
Form Supplied: 1 dose vials
Source:
in January).,
1 on.
05 am.
Approved For Release 1999/09/10 : CIA-RDP83-00423R000700410009-0
 ? Approved For Release 1999/09/10 : CIA-RDP83-00423R000700410009-0
Fore
Atoximicina, or Atralmicina
Description: The formula is as follows: 0Q 000 units
Procaine Penicillin G 3 s
Potassium Penicillin 100,000 units
Streptomycin ;Sulfate) 0.25 g.
25X1 X6 Dihydrostreptomycin 0.25 g.
Paolo Cocco Atoximicina
Cloromisan Lauziei?
scription: Capsule - each one containing:
Chloramphenicol M.A. XIV 0.25 gma
Dihydrostreptomycin Sulfate (equiva-
1_ent to streptomycin base) 0.05 gm.
Indications: The combination of these two drugs
extends and strengthens the antibacterial
spectrum of each.
Administrations: Best resilts are obtained by administering
2 capsules a day -- or approximately 50 mmg.
per kilo of body weight. In case of a fever
the second or third day, use 1 capsule every
four to six hours for 6 to 8 days.
Form Supplied: Bottles of 12,
ointment
Description: Eacbe contains:
Chl.oramphenicod. U.S.P., I gm.
Dihydrostreptomycin Sulfate (as above) 0.05 g.
Propilparaben 0,02 g.
Lanolin 30 g.
Vaseline 58.93 g.
Alcohol
Indications: Used in treatment of skin lesions, derma-
tosis and wounds caused by Gr&m-negative
bacteria or in cases where the cause of
infection is not Down.
Administration: Use sufficient ointment, to cover the af-
fected parts. Repeat as often as necessary.
Form Supplied: Tubes of 28 g.
Suppositories
Description: Each suppository contains:
Chloramphenico]. 0.25 g.
Dihydrostreptomycin Sulfate (as above) 0.05 g.
Propilparaben 0.0004 g.
Cocoa-butter
Indications: Same as the capsules but can be used
where the patient cannot respond to oral
treatment because of nausea or vomiting
due to some gastro-intestinal infections or
pertusis,
Administration: In case of whooping cough in children of six months-
Use 1 suppository in divided doses for four days,
~ For children five years or older - Use 1 to 4
99QJQ ff m?P 'Od423A00l0 160@Y?
Approve Rd Rdase I
Form Supplied: Boxes of 6 suppositories.
Source:
 Approved For Release 1999/09/10 : CIA-RDP83-00423R000700410009-0
-5-
Estrepto-talil Linner
Description: This contains:
Streptomycin Sulfate 0.080 Or.
Sulfathiazole 0.300 Or.
Sulfadiazine 0.125 Or.
Sulfamerazine 0.125 Gr.
Bacterial antigens (Enteric) 10 million
Indications: Enteric bacterial infections, both acute
and chronic. Also pre- and post-,operatively,
particularly in abdominal surgery.
Administration: Initially 4 tablets and then continue with
2 tablets every 4 hours. In case of pro-
nounced diarrhea the cream is recommended.
Children 4 teaspoonfuls initially; continue
with 2 teaspoonfuls every four hours.
Form Supplied: Cream w- Bottles of 100 cc.
Source: 25X1 X6 Tablets - Tubes of 20
Estricilina
bescript on: Each vial contains:
Dihydrostreptomycin Sulfate -- equivalent
to 0.5 g,. of Streptomycin base.
Procaine Penicillin G 300,000 units
Penicillin 0 Crystalline 100,000 units
Form Supplied: 1 Bottle of 5 cm3 with 1 vial of
sterile solution of Sodium Chlorate to
25X1X6 0m85g.%
Nebacetin
escript on: Each gm or ml, contains:
Neomycin 5 mg.
Bacitracin 250 units
Form Supplied: Dry powder for aqueous solution -
Bottles of 10 and 30 ml,
Salve - ophthalmic ointment - Tubes of 5 g.
25X1 X6 and 20 g.
Ophtovit
cscript
ion: Penicillin
Streptomycin
25X1 X6 Vitamin A
Sulfathiol
Indications: Infections of the eye
Form Supplied:
Source:
20,000 U.
0.10 gr,
10,000 U
1 gr.
25X1X6
Neotrizine Savorets in Venezuela under the new
trade name shown above,
Approved For Release 1999/09/10 : CIA-RDP83-00423R000700410009-0
 Approved For Release 1999/09/10 : CIA-RDP83-00423ROO0700410009-0
Penichicle Senosiain
escription: Each piece contains:
Potassium Penicillin G, Crystalline 10,000 U,0.
Chicle, sugar, mint, c.b.p.
Indications: Used in treatment of mouth and throat
infections due to germs sensitive to
the action of Penicillin.
Acute and chronic catarrhal and amigdilites,
Vincent's Angina, Stomatitis and Gingivitis.
Administration: Chew one piece every 2 to 3 hours,
according to the severity of the infection.
Form Supplie?5X1 X6 Boxes of 5, 10 and 20 tablets.
Source :
Penisul S I le
emotion: i tablets, each one containing:
Sodium Penicillin Cryst.
Suifadi azine
Talc, sugar, licorice
stearate.
Fortified
oadiam 'enicillin
Indications:
Administration:
25X1X6
Form Supplied:
Rafacombin
epn:
Administration:
Form Supplied:
Source:
Sulfadiazine
Sulfametazine
Excipient
and magnesium
5,833 Un.
0.11. gr.
G, Cryst. 150,000 Un.
0.15 gr.
0.15 gr.
0.6 gr.
Infections of the mouth and pharynx
Dissolve slowly in the mouth - 1 tablet
every 2 hours. Doctor may prescribe
other dosages.
Bottles of 25 tablets
Each vial contains:
Streptomycin 1 gr.
Penicillin 400,000 units
Tuberculosis and infections due to
Streptomycin and Penicillin sensitive
organisms.
Intramuscular
In vials 25X1 X6
Stre tonazid
scr p ion: Each vial contains:
Dihydrostreptomycin
Hydrazide
Indications: Tuberculosis
Form Supplied: Boxes of 1 vial
Source:
S__t__r__e_~pto~~tibina
escr~iption:
Approved R i A
Source:
25X1X6
1 g,
0.25 g.
This is the first molecular combination of
dihydrostreptomycin and an isonicotinyl-
21 ---cpOrWjities.
 Approved For Release 1999/09/10 : CIA-RDP83-00423R000700410009-0
Suerbional
-i?eseription: This product contains penicillin (either 500,000
or 1,000,000 units) and streptomycin.
Administration: 1 injection every 24 hours. If a larger dose
25X1X6 is needed a second injection can be given within
12 to 16 to 18 hours.
S~rnergistine
Description: Each vial contains:
Streptomycin .5 Or,
Penicillin 400,000 units
Indications: Tuberculosis and infections due to
Streptomycin and Penicillin sensitive
25X1 X6 organisms,,
Administration:
Source:
Trisul-Pen
]Description:
Indications:
Administration:
Form Supplied:
Source :
25X1X6
Tirobacin
Description:
Indications:
Administration:
Form Supplied:
Source: 25X1 X6
ii0khmmil
White tablets, each one containing:
Potassium Penicillin G 50?000 U.Z.
Sulfadiazine 0.166 gr.
Sulfamerazine -0.166 gr.
Sulfametazine 0.166 gr.
Excipient
To be used according to doctor's instructions.
Orally as indicated by doctor.
Bottles of 20 tablets
Each lozenge contains:
Bacitracin
Tyrothrycin
Benzocaine
.cipient
Mouth and throat infections
Orally - to be chewed slowly
Thiocillin Topical Ointment. Ophthalmic Ointment
Description: Each contains :
Penicillin
Sulfathiazole
Vitamin A
Vitamin D
Indications: Skin infections, eye infections
Form Supplied: Tubes of 20 gr. - topical, ointment
Tubes of 8 gr. -- ophthalmic ointment
1 mgr.
1 mgr.
2.5 mgr.
3,000 units
0.50
5,000 U.
3,000 U.
25X1X6
Approved For Release 1999/09/10 : CIA-RDP83-00423R000700410009-0